Interleukin-6 induces demargination of intravascular neutrophils and shortens their transit in marrow.

Recombinant human interleukin-6 (IL-6) causes both a thrombocytosis and leukocytosis. The thrombocytosis is caused by an accelerating thrombocytopoiesis, but the mechanism of the leukocytosis is unknown. This study was designed to determine the relative contributions of marrow stimulation and intravascular demargination to the IL-6 induced neutrophilia. IL-6 (2 microgram/kg), administered intravenously to rabbits, caused a biphasic neutrophilia with an initial peak at 3 h and a second peak at 9 h. Using the thymidine analog 5'-bromo-2'-deoxyuridine (BrdU) to label dividing polymorphonuclear leukocytes (PMNs) in the bone marrow, we showed that IL-6 treatment mobilizes PMNs from the marginated pool into the circulating pool at 2-6 h with a decrease in L-selectin expression on PMNs and also accelerates the release of PMNs from the postmitotic pool in the bone marrow at 12-24 h. We have concluded that IL-6 causes a biphasic neutrophilia wherein the first peak results from the mobilization of PMNs into the circulating pool from the marginated pool and the second peak results from an accelerated bone marrow release of PMNs.

[1]  T. Hirano,et al.  Induction of rat acute‐phase proteins by interleukin 6 in vivo , 1988, European journal of immunology.

[2]  S. Deventer,et al.  Modulation of Cytokine Release and Neutrophil Function by Granulocyte Colony-Stimulating Factor During Endotoxemia in Humans , 1997 .

[3]  Y. Yamaguchi,et al.  Blood concentrations of polymorphonuclear leucocyte elastase and interleukin‐6 are indicators for the occurrence of multiple organ failures at the early stage of acute pancreatitis , 1998, Journal of gastroenterology and hepatology.

[4]  J. Hogg,et al.  Polymorphonuclear Leukocytes Released from the Bone Marrow Preferentially Sequester in Lung Microvessels , 1997, Microcirculation.

[5]  L. Gibson,et al.  Interleukin-6 production by human neutrophils after Fc-receptor cross-linking or exposure to granulocyte colony-stimulating factor. , 1998, Blood.

[6]  J. Hogg,et al.  Polymorphonuclear leukocyte (PMN) migration in streptococcal pneumonia: comparison of older PMN with those recently released from the marrow. , 1996, American journal of respiratory cell and molecular biology.

[7]  D. Kwiatkowski,et al.  Systemic cytokine response after major surgery , 1992, The British journal of surgery.

[8]  J. Hogg,et al.  Polymorphonuclear leukocyte transit times in bone marrow during streptococcal pneumonia. , 1996, The American journal of physiology.

[9]  C. Verfaillie,et al.  Human CD34(+) bone marrow cells regulate stromal production of interleukin-6 and granulocyte colony-stimulating factor and increase the colony-stimulating activity of stroma. , 1998, Blood.

[10]  A. Ridderstad,et al.  Cytokines in rheumatoid arthritis. , 1991, Annals of medicine.

[11]  D. Metcalf,et al.  Recombinant human leukemia inhibitory factor induces acute phase proteins and raises the blood platelet counts in nonhuman primates. , 1993, Blood.

[12]  M. Ahern,et al.  Effects of ex vivo manipulation on the expression of cell adhesion molecules on neutrophils. , 1995, Journal of immunological methods.

[13]  N. Murakami,et al.  Fever and acute-phase response induced in rabbits by intravenous and intracerebroventricular injection of interleukin-6. , 1991, Cytokine.

[14]  D. Papanicolaou,et al.  Acute and delayed effects of a single-dose injection of interleukin-6 on thyroid function in healthy humans. , 1998, Metabolism: clinical and experimental.

[15]  H Stein,et al.  Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes). , 1984, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[16]  J. Hogg,et al.  Glucocorticoid-induced granulocytosis: contribution of marrow release and demargination of intravascular granulocytes. , 1998, Circulation.

[17]  E. Stanley,et al.  Regulation of very primitive, multipotent, hemopoietic cells by hemopoietin-1 , 1986, Cell.

[18]  G. Volckaert,et al.  Structural analysis of the sequence coding for an inducible 26-kDa protein in human fibroblasts. , 1986, European journal of biochemistry.

[19]  S. Burstein,et al.  Thrombocytopoiesis in normal and sublethally irradiated dogs: response to human interleukin-6. , 1992, Blood.

[20]  J. Hogg,et al.  The effect of glucocorticoids on the expression of L-selectin on polymorphonuclear leukocyte. , 1999, Blood.

[21]  T. Ulich,et al.  In vivo hematologic effects of recombinant interleukin-6 on hematopoiesis and circulating numbers of RBCs and WBCs. , 1989, Blood.

[22]  W. Roediger,et al.  Endocrine and cytokine changes during elective surgery. , 1994, Journal of clinical pathology.

[23]  T. Sjöstrand.  Regulation of blood volume. , 1976, Scandinavian journal of clinical and laboratory investigation.

[24]  E. Elson,et al.  Mechanics of stimulated neutrophils: cell stiffening induces retention in capillaries. , 1989, Science.

[25]  D. Rennick,et al.  Interleukin-6 interacts with interleukin-4 and other hematopoietic growth factors to selectively enhance the growth of megakaryocytic, erythroid, myeloid, and multipotential progenitor cells. , 1989, Blood.

[26]  J. Hogg,et al.  A non-radioisotopic method for tracing neutrophils in vivo using 5'-bromo-2'-deoxyuridine. , 1994, American journal of respiratory cell and molecular biology.

[27]  J. Hogg,et al.  Leukocytosis of exercise: role of cardiac output and catecholamines. , 1986, Journal of applied physiology.

[28]  M. Ogawa,et al.  Synergistic interaction between interleukin-6 and interleukin-3 in support of stem cell proliferation in culture. , 1988, Blood cells.

[29]  J. Ihle,et al.  Synergistic factors for stem cell proliferation: further studies of the target stem cells and the mechanism of stimulation by interleukin-1, interleukin-6, and granulocyte colony-stimulating factor. , 1988, Blood.

[30]  C. Elbim,et al.  Interactions between neutrophils and cytokines in blood and alveolar spaces during ARDS. , 1996, American journal of respiratory and critical care medicine.